Clinical

Dataset Information

0

Cancer therapy with vaccination using HLA-A02-restricted peptide from RNF43: a phase I study in patients with unresectable colorectal cancer


ABSTRACT: Interventions: Vaccination using epitope peptide from RNF43 Primary outcome(s): safety Study Design: Single arm Non-randomized

DISEASE(S): Unresectable Colorectal Cancer

PROVIDER: 2616205 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2619184 | ecrin-mdr-crc
| 2616404 | ecrin-mdr-crc
| 2055342 | ecrin-mdr-crc
| 2616206 | ecrin-mdr-crc
| 2616285 | ecrin-mdr-crc
2019-08-06 | GSE85440 | GEO
| 2616207 | ecrin-mdr-crc
| 2616208 | ecrin-mdr-crc
2022-12-14 | GSE206764 | GEO
| 2623536 | ecrin-mdr-crc